KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Times Interest Earned (2016 - 2017)

Teva Pharmaceutical Industries filings provide 9 years of Times Interest Earned readings, the most recent being $0.0 for Q4 2017.

  • On a quarterly basis, Times Interest Earned rose 100.01% to $0.0 in Q4 2017 year-over-year; TTM through Sep 2018 was $0.0, a 276.19% increase, with the full-year FY2017 number at -$19.98, down 5396.12% from a year prior.
  • Times Interest Earned hit $0.0 in Q4 2017 for Teva Pharmaceutical Industries, up from $0.0 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $16.15 in Q2 2015 to a low of -$29.21 in Q4 2014.
  • Median Times Interest Earned over the past 5 years was $4.12 (2016), compared with a mean of $3.84.
  • Biggest five-year swings in Times Interest Earned: soared 1382.3% in 2013 and later plummeted 407.79% in 2014.
  • Teva Pharmaceutical Industries' Times Interest Earned stood at $9.49 in 2013, then plummeted by 407.79% to -$29.21 in 2014, then soared by 145.53% to $13.3 in 2015, then crashed by 101.33% to -$0.18 in 2016, then surged by 100.01% to $0.0 in 2017.
  • The last three reported values for Times Interest Earned were $0.0 (Q4 2017), $0.0 (Q3 2017), and -$0.0 (Q2 2017) per Business Quant data.